| Methods for gene modification of hematopoietic cells |
2021-1-28 |
2021-3-25 |
|
| Gene therapy vectors for treatment of danon disease |
2021-1-08 |
2021-12-09 |
|
| Gene therapy for cns degeneration |
2020-10-21 |
2020-11-30 |
|
| Compositions and methods for stem cell transplant |
2020-10-08 |
2020-11-30 |
|
| Gene therapy vectors for infantile malignant osteopetrosis |
2020-5-22 |
2022-7-14 |
|
| Gene therapy vectors for the treatment of darunavir disease |
2020-2-12 |
2021-10-15 |
|
| Production methods for viral vectors |
2019-8-16 |
2020-2-20 |
|
| Anhydrous polymorphs of [(2r,3s,4r,5r)-5-(6-(cyclopentylamino)-9h-purin-9-yl)- … |
2017-7-10 |
2018-2-15 |
|
| Ophthalmic formulations |
2016-11-08 |
2017-6-01 |
|
| Method of reducing intraocular pressure in humans using n6 - … |
2016-5-26 |
2016-8-18 |
|
| Combination, kit and method of reducing intraocular pressure |
2016-5-18 |
2016-12-22 |
|
| Methods of preventing, reducing or treating macular degeneration |
2015-12-02 |
2017-11-29 |
|
| A method of providing ocular neuroprotection |
2014-3-14 |
2014-9-25 |
|
| Method of reducing intraocular pressure in humans |
2013-4-03 |
2013-8-22 |
|
| Purine derivatives as adenosine a1 receptor agonists and methods of use thereof |
2013-3-18 |
2013-6-13 |
|
| Adenosine compounds and their use thereof |
2011-3-25 |
2011-10-06 |
|
| Combination compositions of adenosine A1 agonists and carbonic anhydrase … |
2011-3-18 |
2017-5-23 |
2017-5-23 |
| Combination compositions of adenosine a1 agonists and non-selective beta- … |
2011-3-18 |
2016-12-07 |
2016-12-07 |
| Purine derivatives and methods of use thereof |
2010-11-12 |
2011-3-10 |
|
| Ophthalmic formulation and method of manufacture thereof |
2010-10-26 |
2012-9-05 |
|
| Antibodies against flagellin and uses thereof |
2010-3-04 |
2010-9-23 |
|
| Indenoisoquinolinone analogs and methods of use thereof |
2009-12-11 |
2010-7-15 |
|
| Substituted tetracyclic 1h-indeno [1,2-b]pyridine-2(5h)-one analogs thereof and … |
2009-12-08 |
2010-10-14 |
|
| N-benzyl substituted pyridyl porphyrin compounds and methods of use thereof |
2009-11-20 |
2010-5-06 |
|
| Method of preventing contrast-induced nephropathy |
2008-12-30 |
2009-10-15 |
|
| Antibodies against flagellin and uses thereof |
2008-9-05 |
2009-8-20 |
|
| Isoquinoline derivatives and methods of use thereof |
2008-6-16 |
2008-10-23 |
|
| Indenoisoquinolinone analogs and methods of use thereof |
2008-2-28 |
2008-9-04 |
|
| Pyridyl-substituted porphyrin compounds and methods of use thereof |
2007-7-19 |
2008-1-10 |
|
| Tetracyclic benzamide derivatives and methods of use thereof |
2007-4-12 |
2007-10-25 |
|
| Purine compounds and methods of use thereof |
2007-3-22 |
2007-10-04 |
|
| Purine compounds and methods of use thereof |
2007-3-22 |
2009-4-08 |
|
| Purine derivatives and methods of use thereof |
2006-11-30 |
2007-6-07 |
|
| Isoqunoline compounds and methods of use thereof |
2006-2-15 |
2007-12-26 |
|
| Tetracyclic Sulfonamide Compounds and methods of use thereof |
2006-2-15 |
2006-12-21 |
|
| Tetracyclic Amino and Carboxamido Compounds and methods of use thereof |
2006-2-15 |
2006-9-08 |
|
| Isoquinoline derivatives and methods of use thereof |
2005-7-08 |
2008-7-01 |
2008-7-01 |
| Methods for treating or preventing erectile dysfunction or urinary incontinence |
2005-6-15 |
2007-5-16 |
|
| Purine derivatives as adenosine A1 receptor agonists and methods of use thereof |
2005-5-25 |
2007-8-01 |
|
| Pyridyl-substituted porphyrin compounds and methods of use thereof |
2005-3-25 |
2007-7-11 |
|
| Tetracyclic lactam derivatives and uses thereof |
2005-2-25 |
2007-8-08 |
|
| Isoquinoline derivatives and methods of use thereof |
2005-2-25 |
2006-11-22 |
|
| 5-Aryltetrazole compounds and uses thereof |
2005-1-06 |
2006-11-14 |
2006-11-14 |
| 5-aryltetrazole compounds and uses thereof |
2003-7-17 |
2005-11-09 |
|
| Nucleoside compounds and compositions thereof |
2002-12-16 |
2005-6-07 |
2005-6-07 |
| Substituted indeno[1,2-c]isoquinoline derivatives and methods of use thereof |
2002-8-30 |
2003-6-05 |
|
| Cell-based assay for detecting activation of poly (ADP-ribose) polymerase |
2002-4-18 |
2002-11-07 |
|
| Inosine compounds and their use for treating or preventing an inflamation or a … |
2002-3-26 |
2002-10-08 |
|
| Inosine compounds and their use for treating or preventing an inflamation or a … |
2002-3-26 |
2004-1-28 |
|
| Automatic provisioning of protection circuits in a communications network |
2000-6-01 |
2005-1-25 |
2005-1-25 |